2.28
+0.15(+7.04%)
Currency In USD
| Previous Close | 2.13 |
| Open | 2.16 |
| Day High | 2.31 |
| Day Low | 2.16 |
| 52-Week High | 6.71 |
| 52-Week Low | 1.76 |
| Volume | 31,048 |
| Average Volume | 548,832 |
| Market Cap | 3.12M |
| PE | -0.62 |
| EPS | -3.69 |
| Moving Average 50 Days | 3.46 |
| Moving Average 200 Days | 3.86 |
| Change | 0.15 |
If you invested $1000 in Arcadia Biosciences, Inc. (RKDA) 10 years ago, it would be worth $1.06 as of January 07, 2026 at a share price of $2.28. Whereas If you bought $1000 worth of Arcadia Biosciences, Inc. (RKDA) shares 5 years ago, it would be worth $20.58 as of January 07, 2026 at a share price of $2.28.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources
GlobeNewswire Inc.
Dec 26, 2025 1:02 PM GMT
DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that on December 24, 2025, it received a notice from Roosevelt Resources, LP, terminating
Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights
GlobeNewswire Inc.
Nov 07, 2025 9:05 PM GMT
-- Zola® year-to-date revenues increase 26% year over year ---- Arcadia gross profit margins exceed 30% for 11th straight quarter ---- Arcadia cash balance declines by only $257K to $1.1M -- DALLAS, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosci
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire Inc.
May 08, 2025 12:02 PM GMT
-- Revenues increase 22% year over year driven by 90% growth in Zola® ---- Arcadia sells patents for $750K and eliminates $1M in liabilities ---- Roosevelt agreement amended to provide greater certainty regarding exchange ratio -- DALLAS, May 08, 20